EICHOR
● Completed
A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
Condition: Lyme Disease · Sponsor: ModernaTX, Inc.
About this study
The purpose of this study is to evaluate the safety and immunogenicity in parallel of heptavalent mRNA-1975 and monovalent mRNA-1982 against Lyme disease in healthy adult participants.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (20)
| Clinical Research Consulting, LLC | Milford, Connecticut, United States | — |
| Stamford Therapeutics Consortium | Stamford, Connecticut, United States | — |
| Chase Medical Research, LLC | Waterbury, Connecticut, United States | — |
| Encore Research Group-Jacksonville Center for Clinical Research | Jacksonville, Florida, United States | — |
| University Clinical Research-DeLand, LLC d/b/a Accel Research Sites | Lake Mary, Florida, United States | — |
| Clinical Research Atlanta, headlands LLC | Stockbridge, Georgia, United States | — |
| Johnson County Clin-Trials, Inc. (JCCT) | Lenexa, Kansas, United States | — |
| Centennial Medical Group | Columbia, Maryland, United States | — |
| Advanced Primary and Geriatric Care | Rockville, Maryland, United States | — |
| DM Clinical Research - Brookline | Brookline, Massachusetts, United States | — |
| Clinical Research Institute, Inc. | Minneapolis, Minnesota, United States | — |
| Meridian Clinical Research - Omaha | Omaha, Nebraska, United States | — |
+ 8 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.